<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="czx101-T2" orientation="portrait" position="float">
 <label>Table 2.</label>
 <caption>
  <p>Common indicators/targets by category</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="1" colspan="1"/>
    <th rowspan="1" colspan="1">Sex-disaggregated</th>
    <th rowspan="1" colspan="1">Non-sex disaggregated</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="1" colspan="1">Epidemiology</td>
    <td rowspan="1" colspan="1">HIV prevalence in the population aged 15–24 (disaggregated by sex and urban/rural)—(Rwanda NSP 2013–18)</td>
    <td rowspan="1" colspan="1">HIV prevalence in youth ages 15-24—(Republic of Congo NSP 2009–13)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Prevention</td>
    <td rowspan="1" colspan="1">Men and women aged 15-49 who had 2 or more sexual partners in the last 12 months who reported using a condom during the last sexual intercourse to increase from 52.3% for men and 37.5% for women in 2009 to 80% for men and 70% for women by 2015/16—(Lesotho NSP 2011–16)</td>
    <td rowspan="1" colspan="1">Proportion of people aged 15-49 years who always use condoms with non-regular partners in the last 12 months—(Botswana NSP 2010–16)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Testing and Linkage</td>
    <td rowspan="1" colspan="1">Percentage of women and men aged 15–49 who received an HIV test in the last 12 months and who know the results of the last test—(Malawi NSP 2011–16)</td>
    <td rowspan="1" colspan="1">Percent of adults that are tested and know their serostatus—(
     <xref rid="czx101-B30" ref-type="bibr">Republique de Centraafricaine (CAR), Comite National de Lutte Contre le SIDA</xref> 2012–16)
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Treatment</td>
    <td rowspan="1" colspan="1">Percent of people per year becoming eligible who receive ART (reported for men and women)—(South Africa NSP, 2012–16)</td>
    <td rowspan="1" colspan="1">Improved coverage of ARV treatment—(Zimbabwe NSP, 2015–18)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Retention</td>
    <td rowspan="1" colspan="1">Percentage of people (reported as men and women separately) who initiated ART who are alive and on treatment at 12, 24, 36 and 60 months—(Zambia NSP 2014–16)</td>
    <td rowspan="1" colspan="1">Increase retention to antiretroviral treatment after three years from 52% to 70% by 2019—(Mozambique NSP 2015–19)</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
